| Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541) |
|---|
| 02/25/2004 | EP1390023A2 Pharmaceutical salts |
| 02/25/2004 | EP0973723B1 A process for the preparation of an aminoalcohol |
| 02/25/2004 | EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| 02/25/2004 | CN1478067A O-substituted 6-methyl-tramadol derivatives |
| 02/25/2004 | CN1477948A Novel coupler for use in oxidative hair dyeing |
| 02/24/2004 | US6696610 Continuous preparation of monoethanolamine, diethanolamine and triethanolamine |
| 02/24/2004 | US6696571 Process for producing α-aminoketones |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/24/2004 | CA2332847C Process for the preparation of protected 3-amino-1,2-dihydroxypropane acetal and derivatives thereof |
| 02/24/2004 | CA2086372C Process for the preparation of tertiary amines methylated by the reaction of hexamethylenetetramine with amines or nitriles |
| 02/19/2004 | WO2002091989A3 Antiviral therapies using polyamine or polyamine analog-amino acid conjugates |
| 02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 02/19/2004 | US20040034103 Cdc25 photophatase inhibitors |
| 02/19/2004 | US20040034080 Comprises catalytic hydroformylation/hydrocarbonylation and reductive amination using a transition metal catalyst |
| 02/19/2004 | US20040033986 Anti tubercular drug: compositions and methods |
| 02/18/2004 | EP1233990B1 Method for producing mannich adducts that contain polyisobutylene phenol |
| 02/18/2004 | EP1171416B1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 02/18/2004 | CN1138772C Process for producing benzothiophenecarboxylic acid amide derivatives |
| 02/12/2004 | WO2004013069A1 A process for the optical resolution of a precursor of sclareolide |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | US20040030197 Process for the synthesis of phenols from arenes |
| 02/12/2004 | US20040030144 Reacting an amino acid with organometallic compound; cyclization |
| 02/12/2004 | US20040030131 Central nervous system disorders |
| 02/12/2004 | US20040029929 Aminoadamantane derivatives as therapeutic agents |
| 02/11/2004 | EP1123271A4 Novel amine and quaternary ammonium compounds made from ketones and aldehydes, and compositions containing them |
| 02/11/2004 | EP1089961B1 Benflumetol derivatives and their use against parasitical protozoa and trematodes |
| 02/11/2004 | CN1474689A CDC25 phosphatase inhibitors |
| 02/11/2004 | CN1474680A Novel coupler for use in oxidative hair dyeing |
| 02/11/2004 | CN1137876C Process for convertnig (+)-pseudo-ephedrin to (-)-ephedrin |
| 02/10/2004 | US6689916 Tolterodine and analogues thereof, as well as to novel intermediates |
| 02/10/2004 | US6689912 Methods for preparing O-desmethylvenlafaxine |
| 02/10/2004 | US6689174 N-benzyl-p-phenylenediamine-derivatives containing coloring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
| 02/10/2004 | CA2093488C Liquid antioxidants as stabilisers |
| 02/05/2004 | WO2004011417A1 N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 02/05/2004 | WO2004011416A1 CRYSTALLINE β2 ADRENERGIC RECEPTOR AGONIST |
| 02/05/2004 | CA2493975A1 N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 02/05/2004 | CA2493128A1 Crystalline .beta.2 adrenergic receptor agonist |
| 02/04/2004 | EP1386908A1 Amine derivative with potassium channel regulatory function, its preparation and use |
| 02/04/2004 | EP1385928A1 Method for purifying long-chain alkyl phenols and the mannich adducts thereof |
| 02/04/2004 | EP1385857A1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
| 02/04/2004 | EP1385625A2 A nickel-rhenium catalyst for use in reductive amination processes |
| 02/04/2004 | EP1183227B1 P-diaminobenzene derivatives and dyes containing said compounds |
| 02/04/2004 | CN1472204A Condensed products of hydroxy aromatic mannich alkali and its use as ash disperser in lubricant composition |
| 02/04/2004 | CN1137086C 2-aminopropane-1,3-diol compounds, medical use therof and intermediates in synthesizing the same |
| 02/04/2004 | CN1137085C Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives |
| 02/04/2004 | CN1137084C Aryne intermediates and process for preparation thereof |
| 02/04/2004 | CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/03/2004 | US6686505 Process for producing optically active amino alcohols and intermediates therefore |
| 02/03/2004 | US6686490 Non-metallocene pre- catalyst featuring a diamine diphenolate complex |
| 02/03/2004 | US6685751 Substituted 1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 01/30/2004 | CA2436347A1 Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions |
| 01/29/2004 | WO2004009067A1 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence |
| 01/29/2004 | WO2004009034A2 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019117 Anti tubercular drug: compostions and methods |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019087 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019078 Substituted tetrahydroisoquinoline compounds, methods of making, and their use |
| 01/29/2004 | US20040019043 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019021 Linked cyclitols and their polysulfated derivatives |
| 01/29/2004 | US20040016063 1,3-Dihydroxybenzene derivatives and colorants containing said compounds |
| 01/29/2004 | DE10233048A1 Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken Use of 1-phenyl-3dimethylamino-propane compounds for the therapy of depressive symptomatology |
| 01/29/2004 | DE10228763A1 Monomere für Isoliermaterialien in Aluminium- und Kupfertechnologien Monomers for insulation materials in aluminum and copper technologies |
| 01/29/2004 | CA2493127A1 Thiomolybdate analogues and uses thereof |
| 01/28/2004 | EP1384708A1 Process for the manufacture of form I of nolomirole hydrochloride |
| 01/28/2004 | CN1470501A Insulated material monomer in aluminium and copper technology |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/27/2004 | US6683217 Process for manufacturing triethanolamine and product obtained |
| 01/27/2004 | US6683115 β2-adrenergic receptor agonists |
| 01/27/2004 | US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 01/22/2004 | WO2004007423A1 Novel salt forms of poorly soluble probucol esters and ethers |
| 01/22/2004 | US20040015015 Vasoconstrictors that are used to prolong the activity of local anesthetics in dental preparations |
| 01/22/2004 | CA2492433A1 Organic amine salts of poorly soluble probucol esters and ethers |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1382332A1 Method for inhibiting bacterial or fungal growth using a polyamine derivative as complexing agent |
| 01/21/2004 | EP1381597A2 Processes and intermediates for preparing benzyl substituted epoxides |
| 01/20/2004 | US6679663 Locking nut, bolt and clip systems and assemblies |
| 01/15/2004 | WO2004006355A2 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | WO2004006354A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | WO2004006352A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | WO2004005406A2 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | WO2004005288A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | WO2004005251A1 Phenol derivatives and method of use thereof |
| 01/15/2004 | WO2004005239A1 PROCESS FOR THE PREPARATION OF N-MONOSUBSTITUTED β-AMINO ALCOHOLS |
| 01/15/2004 | WO2004005229A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | US20040010038 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
| 01/15/2004 | CA2492692A1 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | CA2491020A1 Phenol derivatives and method of use thereof |
| 01/14/2004 | EP1380568A2 Perfluoroalkylaniline derivatives |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/13/2004 | US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents |
| 01/13/2004 | US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis |
| 01/13/2004 | US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease |
| 01/13/2004 | US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |